Drug Discovery 2019 - Looking back to the future
Poster
89

Antagonist binding kinetics at the human D1 dopamine receptor determined by HTRF assay

Authors

K Sengmany1; K W Wong1; S Charlton1; N Holliday1
1 Excellerate Bioscience, UK

Abstract

Introduction. The binding kinetics of ligands,
described by their association (kon) and dissociation (koff)
rate constants at the target receptor, significantly influence drug action. For
example, recent studies on the D2 dopamine receptor demonstrate links between agonist
kinetics and observed signalling bias [1], and correlate antipsychotic side
effects with association rates and their potential influence on rebinding [2].
The D1 receptor (D1R) offers an alternate target in ameliorating symptoms of schizophrenia
[3], and while functional effects of D1R antagonists have previously been
assessed [3], less is known about their binding kinetics. Here we develop a
time-resolved fluorescence (HTRF) D1R binding assay, and demonstrate its
applicability in measuring antagonist kinetic parameters by the competition
association method [4].



Methods. Membranes expressing
Terbium-labelled SNAP-tagged human dopamine D1 receptor were generated as
previously described [2]. Binding assays were carried out using SKF83566-green
(F-SKF) as the fluorescent tracer acceptor (with HTRF measured on a BMG
Pherastar FSX). F-SKF kon and koff were determined by
global fitting of a one-site model (Graphpad Prism) to its association kinetics
at different tracer concentrations.  Competition
association kinetic assays were initiated by adding membranes to a mix of F-SKF
(300nM) and increasing concentrations of unlabelled antagonist, from which
competing ligand kon and koff were determined by the Motulsky-Mahan
(MM) model [4].



Results. The F-SKF kon
was 3.17 ± 0.12x106 M-1min-1, its koff
0.41 ± 0.01min-1, and equilibrium dissociation constant KD 139.1 ± 5.0nM
(n=4), measured at the D1R. Using the MM approach, the kinetics of
representative D1 antagonists SCH-23390, ecopipam (SCH-39166), and clozapine
were also derived (n=3). SCH-23390 and ecopipam had similar kon estimates
(8.89 ± 1.01 x 107 and 8.82 ± 0.63 x 107 M-1
min-1 respectively), while clozapine had a slower on-rate (1.68 ± 0.25
x 107). While SCH-23390 and ecopipam again showed similar koff
values (0.21 ± 0.004 and 0.35 ± 0.02 min-1 respectively), off-rates for clozapine
was markedly faster (5.96 ± 0.61 min-1).



Conclusion. HTRF screening using the F-SKF
tracer offers a robust method to assess antagonist binding kinetics at D1R,
with a homogenous, medium throughput format allowing implementation of such
studies at an early stage in compound profiling.

References



[1]
Klein Herenbrink C et. al., (2016) The role of kinetic context in
apparent biased agonism at GPCRs. Nat
Commun. 24;7:10842.

[2]
Sykes DA et. al., (2017) Extrapyramidal side effects of antipsychotics
are linked to their association kinetics at dopamine D2 receptors. Nat Commun.
2;8(1):763.



[3]
Beaulieu JM, Gainetdinov RR (2011) The physiology, signaling and pharmacology
of dopamine receptors. Pharmacol Rev, 63(1):182-217.



[4]
Motulsky HJ, Mahan LC (1984) The kinetics of competitive radioligand binding
predicted by the law of mass action. Mol Pharmacol. 25(1):1-9.





 

Programme

Hosted By

ELRIG

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis